Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health,Oncology
Reference25 articles.
1. Unger JM, Vaidya R, Hershman DL, Minasian LM, Fleury ME (2019) Systematic review and meta-analysis of the magnitude of structural, clinical, and physician and patient barriers to cancer clinical trial participation. J Natl Cancer Inst 111(3):245–255. https://doi.org/10.1093/jnci/djy221
2. American Cancer Society Cancer Action Network. Barriers to patient enrollment in therapeutic clinical trials for cancer: a landscape report. Published online 2018. https://www.fightcancer.org/sites/default/files/National%20Documents/Clinical-Trials-Landscape-Report.pdf. Accessed 9 Aug 2022
3. Sateren WB, Trimble EL, Abrams J et al (2002) How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trials. J Clin Oncol 20(8):2109–2117. https://doi.org/10.1200/JCO.2002.08.056
4. Hamel LM, Penner LA, Albrecht TL, Heath E, Gwede CK, Eggly S (2016) Barriers to clinical trial enrollment in racial and ethnic minority patients with cancer. Cancer Control 23(4):327–337. https://doi.org/10.1177/107327481602300404
5. Back AL, Arnold RM, Baile WF, Tulsky JA, Fryer-Edwards K (2005) Approaching difficult communication tasks in oncology. CA Cancer J Clin 55(3):164–177. https://doi.org/10.3322/canjclin.55.3.164